To Evalute the Analgesic effect of Coenzyme Q10 in Acute Herpes Zoster
Phase 4
- Conditions
- Health Condition 1: B022- Zoster with other nervous system involvement
- Registration Number
- CTRI/2023/07/055198
- Lead Sponsor
- PGIMS ROHTAK
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA grade 1 AND 2
Exclusion Criteria
pregnancy
thyroid
diabetes
liver or renal disease
immunocompromised patient
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evalute the ameliorating effect of Coenzyme Q10 in Acute Herpes ZosterTimepoint: VAS Score will be assessed at 0, 2 and 4 weeks
- Secondary Outcome Measures
Name Time Method ILTimepoint: NI